BioAtla, Inc. SEC filings BCAB

BioAtla, Inc. has 509 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (material agreement, agreement ended, unregistered share sale). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jun 3, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
10-K Annual report Mar 26, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 24, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
10-K Annual report Mar 24, 2021 Dec 31, 2020

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BCAB (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826892

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.